phosphotyrosine has been researched along with fingolimod hydrochloride in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bordin, L; Brunati, AM; Facco, M; Frezzato, F; Pagano, MA; Pavan, V; Ribaudo, G; Semenzato, G; Tibaldi, E; Trentin, L; Trimarco, V; Zagotto, G; Zonta, F | 1 |
1 other study(ies) available for phosphotyrosine and fingolimod hydrochloride
Article | Year |
---|---|
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A.
Topics: Apoptosis; DNA-Binding Proteins; Fingolimod Hydrochloride; Histone Chaperones; HSP90 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylation; Phosphotyrosine; Propylene Glycols; Protein Interaction Maps; Protein Phosphatase 2; Signal Transduction; Sphingosine; src-Family Kinases; Transcription Factors; Tumor Cells, Cultured | 2015 |